Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: Analysis with [123I]IPT single photon emission computed tomography

Journal of the Neurological Sciences

Volumn 244, Issue 1-2, 2006, Pages 103-109

  Im, Joo Hyuk ^a   Chung, Sun J ^a   Kim, Jae Seung ^a   Lee, Myoung C ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Dopamine transporter; Parkinson's disease; Progressive supranuclear palsy; Single photon emission tomography; Striatum; Substantia nigra

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; IODINE 123; N (3 IODOPROPEN 2 YL) 2BETA CARBOMETHOXY 3BETA (4 CHLOROPHENYL)TROPANE; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL GANGLION; CALCULATION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIFFERENTIAL DIAGNOSIS; DOPAMINE UPTAKE; FEMALE; HUMAN; MALE; OCCIPITAL CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BASAL GANGLIA; CAUDATE NUCLEUS; DIAGNOSIS, DIFFERENTIAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PUTAMEN; REFERENCE VALUES; SUPRANUCLEAR PALSY, PROGRESSIVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 33646086230     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.01.006     Document Type: Article

References (44)

1. Gibb W.R.G. The neuropathology of parkinsonian disorders. In: Jankovic, and Tolosa E. (Eds). Parkinson's disease and movement disorders (1988), Urban and Schwarzenberg, Baltimore 205-223
2. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease, a clinico-pathologic study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
3. Jellinger K.A. The neuropathologic diagnosis of secondary parkinsonian syndromes. Adv Neurol 69 (1996) 293-303
4. Rajput A.H., Rozdilsky B., and Rajput A. Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci 18 3 (1991) 275-278
5. Golbe L.I. The epidemiology of PSP. J Neural Transm 42 (1994) S263-S273
6. Golbe L.I. Epidemiology. In: Litvan I., and Agid Y. (Eds). Progressive supranuclear palsy: clinical and research approaches (1992), Oxford University Press, New York 33-43
7. 18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects. J Cereb Blood Flow Metab 13 (1993) 43-56
8. 18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures. J Neurosci Res 27 (1990) 487-493
9. 18F]fluoro-dopa in human positron emission tomographic studies. J Cereb Blood Flow Metab 11 (1991) 898-913
10. Innis R.B., Seibyl J.P., Scanley B.E., Laurelle M., Abi-Dargham A., Wallace E., et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci U S A 90 (1993) 11965-11969
11. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 34 (1993) 423-431
12. 123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 38 4 (1995) 589-598
13. 123I] β-CIT SPECT. Parkinsonism Relat Disord 1 (1995) 47-51
14. Asenbaum S., Brucke T., Pirker W., Podreka I., Angelberger P., Wenger S., et al. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. J Nucl Med 38 (1997) 1-6
15. 123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 46 (1996) 231-237
16. Kim H.J., Im J.H., Yang S.O., Moon D.H., Ryu J.S., Bong J.K., et al. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects. J Nucl Med 38 (1997) 1703-1711
17. 123]IPT and single photon emission tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis. Arch Neurol 57 (2000) 205-208
18. Goodman M., Kung M., Kabalka G., Kung H., and Switzer R. Synthesis and characterization of radioiodinated N-(3-iodopropene-2-yl)-2b-carbomethoxy-3b-(4-chlorophenyl) tropanes: potential dopamine reuptake site imaging agents. J Med Chem 37 (1994) 1535-1542
19. Kung M.P., Essman W.D., Frederick D., Meegalla S., Goodman M., Mu M., et al. I.P.T.: a novel iodinated ligand for the CNS dopamine transporter. Synapse 320 (1995) 316-324
20. Malison R.T., Vessotskie J.M., Kung M.P., McElgin W., Romaniello G., Kim H.J., et al. Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT. J Nucl Med 36 (1995) 2290-2297
21. Mozley P.D., Stubbs J.H., Kim H.J., McElgin W., Kung M.P., Meegalla S., et al. Dosimetry of an iodine-123-labelled tropane to image dopamine transporters. J Nucl Med 37 (1996) 151-159
22. Ichise M., Ballinger J.R., Golan H., Vines D., Luong A., Tsai S., et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SEPCT. J Nucl Med 37 (1996) 513-520
23. CAPIT Committee. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7 (1992) 2-13
24. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47 (1996) 1-9
25. Zea-Ponce Y., Baldwin R.M., Laruelle M., Wang S., Neumeyer J.L., and Innis R.B. Simplified multidose preparation of iodine-123-β-CIT: a marker for dopamine transporters. J Nucl Med 36 (1995) 525-529
26. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 25 (1978) 638-643
27. 123]4-iodolevetimide. J Cereb Blood Flow Metab 12 (1992) 562-570
28. Laruelle M., van Dyck C., Abi-Dargham A., Zea-Ponce Y., Zoghbi S.S., Charney D.S., et al. Compartmental modeling of iodine-123-iodo-benzofuran binding to dopamine D2 receptors in healthy subjects. J Nucl Med 35 5 (1994) 743-754
29. Gibb W.R. Neuropathology of Parkinson's disease and related syndromes. Neurol Clin 10 (1992) 361-376
30. Hauw J.J., Daniel S., Dickson D., Horoupian D.S., Jellinger K., Lantos P.L., et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44 (1994) 2015-2019
31. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
32. Szabo J. Organization of the ascending striatal afferents in monkeys. J Comp Neurol 189 (1980) 307-321
33. Carpenter M.B., and Peter P. Nigrostriatal and nigrothalamic fibers in the rhesus monkey. J Comp Neurol 144 (1972) 93-116
34. Parent A., Mackey A., and De Bellefeuille L. The subcortical afferents to caudate afferents to caudate nucleus and putamen in primate: a fluorescence retrograde double labeling study. Neuroscience 10 (1983) 1137-1150
35. Fallon J.H., and Moore R.Y. Catecholamine innervation of the basal forebrain: IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180 (1978) 545-580
36. Nauta W.J.H., Smith G.P., Faull R.L.M., and Domesick V.B. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience 3 (1978) 385-401
37. Beckstead R.M., Domesick V.B., and Nauta W.J.H. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res 175 (1979) 191-217
38. Szabo J. Distribution of striatal afferents from the mesencephalon in the cat. Brain Res 188 (1980) 3-21
39. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 318 (1988) 876-880
40. Kish S.J., Shannak K., Rajput A., Deck J.H.N., and Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J Neurochem 58 (1992) 642-648
41. Murray A.M., Weihmueller F.B., Marshall J.F., Hurtig H.I., Gottleib G.L., and Joyce J.N. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 37 (1995) 300-312
42. Ilgin N., Zubieta J., Reich S.G., Dannals R.F., Ravert H.T., and Frost J.J. PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease. Neurology 52 (1999) 1221-1226
43. Mozley P.D., Kim H.J., Gur R.C., Tatsch K., Muenz L.R., McElgin W.T., et al. Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med 37 (1996) 1965-1970
44. 123I]beta-CIT. Mov Disord 14 (1999) 436-442